Crystalline Management Inc. Oyster Point Pharma, Inc. Transaction History

Crystalline Management Inc.

  • $112 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 13, 2023
BUY
$7.95 - $11.68 $90,796 - $133,397
11,421 New
11,421 $128 Million

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Crystalline Management Inc. Portfolio

Follow Crystalline Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crystalline Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crystalline Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email